Analyst Ratings for MEI Pharma (MEIP)
MEIP Rating Summary
MEIP Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.50 (+818.4%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 57%
Avg. $ Target:
$4.50 (+818.4%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 57%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2022 | Wells Fargo | N/A | Downgrade | Equal Weight (Overweight) |
2.00 (13.00) |
1.80 (0.49) |
-72.78% | Details |
| 3/25/2022 | Jefferies | Chris Howerton | Downgrade | Hold (Buy) |
1.00 (4.00) |
1.80 (0.49) |
-72.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
